Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02552316 · ClinicalTrials.gov registry record · NA
Psoriasis Microbiome and Phototherapy
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT02552316: Completed NA study, sponsored by University of Pennsylvania.
NCT02552316 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02552316, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The ASPIRE study is a clinical trial designed to examine the microbes (e.g., bacteria) within psoriasis skin lesions compared with normal skin. The investigators will also examine the effect of NB-UVB (narrow-band ultraviolet B) phototherapy (i.e., light therapy) on skin microbes.
Interventions
- DEVICE NB-UVB Phototherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2014-12 |
| Est. Completion | 2020-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02552316
The ClinicalTrials.gov registry entry for NCT02552316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NB-UVB Phototherapy is the first listed.
NCT02552316 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02552316 about?
NCT02552316 is a clinical study titled "Psoriasis Microbiome and Phototherapy". The ASPIRE study is a clinical trial designed to examine the microbes (e.g., bacteria) within psoriasis skin lesions compared with normal skin. The investigators will also examine the effect of NB-UVB (narrow-band ultraviolet B) phototherapy (i.e., light therapy) on skin microbes.
What is the current status of trial NCT02552316?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2014-12. Estimated completion is 2020-10.
What interventions are being tested in trial NCT02552316?
The interventions under investigation include: NB-UVB Phototherapy (DEVICE).
Who is sponsoring clinical trial NCT02552316?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.